● Terminated

A Phase 2 Randomized Double-Blind, Parallel, Adaptive-Design, Clinical Trial to Evaluate the Safety and Efficacy of NRCT-101SR With NRCT-202XR Compared to NRCT-202XR Alone in Subjects With Attention-Deficit/Hyperactivity Disorder

Condition: ADHD · Sponsor: Neurocentria, Inc.

PhasePhase 2

Planned participants2

Who can joinAll sexes, 13 Years to 17 Years

Healthy volunteersNo

About this study

A combination therapy of NRCT-101 with NRCT-202 is being developed for patients with ADHD.

This description comes directly from the study's public registry record.

Talk to the study team

Contact details are listed per location below or on the registry record.

Always discuss trial participation with your own doctor first.

Locations (5)

Accel Research Site-Maitland Clinical Research Unit	Maitland, Florida, United States	—
iResearch Atlanta	Decatur, Georgia, United States	—
CenExel iRS - iResearch Savannah	Savannah, Georgia, United States	—
Boston Clinical Trials LLC	Boston, Massachusetts, United States	—
Center For Psychiatry and Behavioral Medicine	Las Vegas, Nevada, United States	—

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06673368